Table 4.
Ambivalent Recommenders |
Protocol Followers |
|||
---|---|---|---|---|
OR (95% CI)* | OR (95% CI)* | Engagers (reference) |
p-value | |
Practitioner age | 1.0 (0.9, 1.02) | 1.0 (0.9, 1.02) | 1.0 | .71 |
Practitioner gender (female) | 0.7 (0.4, 1.2) | 0.6 (0.3, 1.02) | 1.0 | .13 |
Practitioner race/ethnicity (Caucasian) | 0.64 (0.3, 1.4) | 0.4 (0.2, 0.8) | 1.0 | .05 |
Suburban location | 2.2 (1.1, 4.1) | 0.9 (0.4, 2) | 1.0 | .03 |
Rural location | 1.5 (0.6, 3.2) | 1 (0.3, 1.4) | 1.0 | .20 |
Located in CDC disparity state** | 0.7 (0.4, 1.2) | 1.1 (0.6, 2) | 1.0 | .27 |
See >25% Medicaid patients | 0.7 (0.4, 1.2) | 3.1 (1.4, 6.9) | 1.0 | p < .001 |
Report financial barriers in practice | 1.2 (0.5, 2.5) | 1.5 (0.6, 3.6) | 1.0 | .67 |
*CI = confidence interval; OR = odds ratio
**CDC designates a US state that has less than 60% of adolescents vaccinated for HPV as a disparity state. Twenty-three states are currently designated as a disparity state.17